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The eﬀects of polyphenols and other bioactives on
human health
César G. Fraga, *a,b,c Kevin D. Croft, d David O. Kennedye and
Francisco A. Tomás-Barberán f
Although deﬁciencies in polyphenol intake do not result in speciﬁc deﬁciency diseases, adequate intake
of polyphenols could confer health beneﬁts, especially with regard to chronic diseases. Tea, cocoa, fruits,
and berries, as well as vegetables, are rich in polyphenols. Flavan-3-ols from cocoa have been found to
be associated with a reduced risk of stroke, myocardial infarction, and diabetes, as well as improvements
in lipids, endothelial-dependent blood ﬂow and blood pressure, insulin resistance, and systemic inﬂam-
mation. The ﬂavonoid quercetin and the stilbene resveratrol have also been associated with cardiometa-
bolic health. Although polyphenols have been associated with improved cerebral blood ﬂow, evidence of
an impact on cognition is more limited. The ability of dietary polyphenols to produce clinical eﬀects may
be due, at least in part, to a bi-directional relationship with the gut microbiota. Polyphenols can impact
the composition of the gut microbiota (which are independently associated with health beneﬁts), and gut
bacteria metabolize polyphenols into bioactive compounds that produce clinical beneﬁts. Another critical
interaction is that of polyphenols with other phytochemicals, which could be relevant to interpreting the
health parameter eﬀects of polyphenols assayed as puriﬁed extracts, whole foods, or whole food extracts.
1. Introduction
The World Health Organization (WHO) has estimated that
52% of premature deaths in 2012 were attributable to non-
communicable diseases (NCDs), with more than 75% being
linked to cardiovascular disease, cancer, diabetes, and chronic
respiratory diseases.1 As a result, NCDs are now considered to
be a major public health concern in developing as well as
developed regions of the world.1 The WHO recommendation
to increase consumption of fruit, vegetables, and fiber is a key
lifestyle change that could help to reduce the risk of these
NCDs.2
In addition to nutrients that are found in fruits and veg-
etables, such as essential vitamins and minerals, there are a
number of plant-derived components,3 including, for example,
fiber, carotenoids, and phytosterols, that could promote
health. In particular, the class of phytochemicals called poly-
phenols may confer health benefits, particularly as they relate
to NCDs.4–7 In contrast to vitamins and minerals and other
nutrients, inadequacies in plant polyphenol intake are not
associated with specific deficiency diseases, making it diﬃcult
to define appropriate reference intake values for these food
components.8 Despite this knowledge gap, many of these com-
pounds have been identified, with some producing promising
results in observational studies and randomized clinical trials
in certain NCDs.9–11 The purpose of this narrative review is to
explore how polyphenols exert health benefits in humans,
alone or in synergy with other plant components.
2. The absorption and metabolism of
polyphenols
The polyphenols constitute a large group of bioactive phyto-
chemicals that include multiple sub-classes such as flavo-
noids, stilbenes, phenolic acids, and lignans.12 Fig. 1 describes
the basic structure of some key classes of these phenolic com-
pounds, as well as some other bioactive phytochemicals, such
as terpenoids (e.g. carotenoids) and nitrogen- (e.g. alkaloids)
and sulfur-containing products (e.g. sulforaphanes, allicin).13
One of the most studied groups of polyphenols is the flavo-
noids, which are structurally based on a 15-carbon skeleton of
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a chromane ring attached to a second aromatic ring (Fig. 2).
The flavonoids can be sub-divided into groups, including
flavan-3-ols, flavonols, flavones, isoflavones, flavanones, and
anthocyanins. Table 1 provides specific examples of these
natural polyphenols and describes some known food sources
for each class.14–16
Naturally occurring flavonoids are stored in plants as glyco-
side and non-glycosylated conjugates, and the nature of the
moiety can influence their later bioavailability in humans.12,17
Flavonoids can be absorbed in the small intestine, where they
are frequently metabolized by phase II enzymes before enter-
ing systemic circulation.17,18 Although a proportion of some
dietary flavonoids are absorbed in the small intestine, a sig-
nificant amount enters the large intestine where the colonic
microbiota further degrade the deconjugated metabolites and
aglycones into readily absorbable molecules, including pheno-
lic acids.18 For example, tomato juice quercetin-3-O-rutinosides
are primarily absorbed in the large rather than the small intes-
tine, and there are multiple methylated and glucuronidated
products that are metabolized by colonic microflora.17 Green
tea flavan-3-ols are also extensively metabolized prior to being
absorbed, initially in the small intestine; a remaining portion
enters the large intestine and is metabolized by the microbiota
to form phenolic acids.17 The available data indicate that
colonic bacteria play a significant role in the absorption of a
host of flavonoids, as well as other phenolic and polyphenolic
compounds, and can determine their bioavailability in sys-
temic circulation. Furthermore, the presence of polyphenols
and their metabolites in the colon can directly impact the
health of the colon and its microbiota, as they persist in the
colon for longer periods of time than in the small intestine.17
3. Interactions between polyphenols
and the microbiome
There is a bi-directional relationship between polyphenols and
the microbiome of the human gut (Fig. 3),11,18–21 that mimics
to some extent the relationship between polyphenols and the
pathogenic and symbiotic microbial population in the root
system of plants.11 Polyphenols can modulate the composition
of an individual’s microbiome.19,21 For example, cocoa flavan-
Fig. 1 Structure of common phytochemicals.
Fig. 2 Basic structure of ﬂavonoids.
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Table 1 Food sources of major polyphenol classes14–16
Polyphenol class Examples Food sources
Flavonols Quercetin Black tea, green tea, red wine, white wine, walnuts, almonds, apple
with peel, blueberries, oranges, dark chocolate, raw spinach, onion,
Brassicaceae products (e.g. kale, broccoli)
Myricetin
Kaempferol
Flavan-3-ols (+)-Catechin Black tea, green tea, red wine, almonds, hazelnuts, apple with peel,
blueberries, dark chocolate(−)-Epicatechin
(+)-Gallocatechin
(−)-Epicatechin-3-gallate
(−)-Epigallocatechin-3-gallate
Flavanones Eriodictyol Citrus fruits and juices, tomatoes and tomato-derived products
Naringenin
Hesperetin
Flavones Apigenin Grain mixtures, vegetable oils, celery, sweet pepper
Luteolin
Isoflavones Daidzein Soy, tofu, legumes
Genistein
Glycitein
Anthocyanins Cyanidin Red wine, blueberries, other berries, pomegranate, blue corn
Delphinidin
Petunidin
Malvidin
Peonidin
Proanthocyanidins Procyanidins (epicatechin oligomers) Grape seed, red wine, bilberry, cranberry, black currant, green tea,
black tea, cocoa, peanuts, pine barkProdelphinidin (epigallocatechin polymers)
Hydroxycinnamates Chlorogenic acid (caﬀeic) Coﬀee, yerba mate, red wine, red fruits, vegetables, whole grains
p-Coumaric acid
Ferulic acid
Sinapic acid
Dihydrochalcones Phloretin Apples
Ellagic acid and
ellagitannins
Ellagic, punicalagin, strictinin, vescalagin,
castalagin, casuarictin
Berries, tropical fruits, pomegranates, nuts
Lignans Secoisolariciresinol, pinoresinol Whole bran cereals, flaxseed
Stilbenes Resveratrol Red wine, grapes
Phenolic acids Benzoic acid derivatives (gallic acid,
protocatechuic acid, p-hydroxybenzoic acid)
Berries, spices, cereals, tea
Coumarins Coumarin Tonka beans, cinnamon
Fig. 3 Polyphenol metabolism in the colon and metabolite absorption.20 GI, gastrointestinal. Reprinted from Molecular Aspects of Medicine, vol 61,
Oteiza PI, Fraga CG, Mills DA, Taft DH, Flavonoids and the Gastrointestinal Tract: Local and Systemic Eﬀects, pp 41–49, copyright 2018, with per-
mission from Elsevier.
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3-ols have been shown to increase the production of butyrate,
and associations have been observed between fermentable
polysaccharides and flavonols and flavan-3-ols.19 Non-extracta-
ble polyphenols (i.e. those that are insoluble and cannot be
extracted with classical solvent extraction techniques) have
been somewhat overlooked for their bioactive properties, but it
has been shown that they persist in the colon for an extended
period, where they are metabolized by gut microbiota to form
more eﬃciently absorbed, active metabolites.22
The composition of an individual’s gut microbiome can
vary depending upon environmental and genetic factors (e.g.
enterotypes, diﬀerences in diversity, and content),23 and the
ability of individuals to metabolize certain polyphenols has
been attributed to distinct phenotypes (i.e. metabotypes).24 For
example, the population can be categorized into three distinct
urolithin metabotypes of ellagitannin that have been
associated with diﬀerences in intestinal microbiota,
specifically Gordonibacter urolithinfaciens and Ellagibacter
isourolithinfaciens.25–27 It has been suggested that the degree of
ellagitannin metabolism, based on the types of bacteria that are
present in the colon, can lead to diﬀering biological eﬀects.28
After the intake of isoflavones, a polyphenol group that has
received interest for its eﬀects in health, the conversion of daid-
zein to equol by the gut microbiota also shows the presence of
an equol producer metabotype and an equol non-producer
metabotype. These metabotypes show diﬀerent distribution
among individuals, and only the equol producers seem to
experience cardiometabolic risk benefits after the intake of soy
isoflavones.29 Since dysbiosis of gut microbiota has also been
associated with the development of a number of NCDs, includ-
ing cardiovascular disease, obesity, and neurodegenerative
diseases,30–32 a positive interaction with polyphenolic com-
pounds has the potential to produce health benefits.20,21
Some polyphenols, such as those found in green and black
tea, can inhibit the growth of detrimental bacteria such as
Helicobacter pylori, Staphylococcus aureus, Escherichia coli,
Salmonella typhimurium, Listeria monocytogenes, and
Pseudomonas aeruginosa, as well as hepatitis C virus, influenza,
HIV, and Candida.33 Other polyphenols, in contrast, can stimu-
late growth or at least change the composition of the micro-
biome in favor of beneficial bacteria including Bifidobacterium
spp., Lactobacillus spp., Akkermansia muciniphila, and
Faecalibacterium prausnitzii and improve the ratio of Firmicutes
to Bacteroidetes.21,33–36 For example, consumption of a pre-
biotic wild blueberry powder drink rich in anthocyanidins for
six weeks was shown to produce a statistically significant
increase in Lactobacillus acidophilus and Bifidobacterium spp.
compared with placebo.37
Polyphenols are metabolized by the microbiome to generate
compounds with potential bioactivity. For example, chloro-
genic acid and related compounds are some of the main bio-
active phenolic compounds present in significant amounts in
the diet. They are metabolized in the gut by the resident micro-
biota, which are responsible for the release of caﬀeic acid and
further metabolism, producing phenyl–propionic, phenyl–
acetic, and benzoic acid derivatives that are then absorbed.38,39
4. The health beneﬁts of polyphenols
The primary mechanism of action of polyphenols was orig-
inally thought to lie in their direct antioxidant eﬀects.
However, these eﬀects are no longer considered to be as rele-
vant in vivo, as these compounds do not reach concentrations
in most tissues that are high enough to have a significant
eﬀect in terms of scavenging free radicals.40–44 However, a
number of other possible biochemical and molecular mecha-
nisms have been identified, including multifarious eﬀects
within intra- and inter-cellular signaling pathways, such as reg-
ulating nuclear transcription factors and fat metabolism, and
modulating the synthesis of inflammatory mediators including
cytokines tumor necrosis factor α, interleukin (IL)-1β, and
IL-6.45,46 For example, certain flavonoids have been shown to
have a role in glucoregulation through downstream signaling
that increases insulin secretion, reduces apoptosis, promotes
β-cell proliferation, and reduces insulin resistance, inflam-
mation, and oxidative stress in muscle and other cells.
Phlorizin is a dihydrochalcone found in apples and apple pro-
ducts that can be absorbed in the small intestine and poten-
tially transported by sodium–glucose transporters (SGLTs).
Phlorizin is a specific and competitive inhibitor of SGLTs in
the intestine (SGLT-1) and kidney (SGLT-2) and as such may be
useful in treating hyperglycemia.47 As a result, flavonoids are
thought to have beneficial eﬀects on obesity and diabetes.48–50
A relevant consideration is the amounts of these com-
pounds that need to be consumed to provide positive health
eﬀects. When the amounts of polyphenols necessary for pro-
ducing health benefits are within the ranges present in com-
monly consumed foods, it is possible to conclude there is an
absence of toxicological danger. A second level is when the
potential eﬀects are observed at levels that require an increase
in the consumption of foods that is tolerable within reason-
able boundaries (e.g. consuming three apples instead of two).
A third level is when the amount needed requires intake levels
attainable via dietary supplements or pharmacological
approaches. In this latter situation, the possibilities of undesir-
able eﬀects are increased, and such possibilities should be
carefully controlled for.
4.1. Eﬀects of polyphenols on cardiometabolic health
Polyphenols from various food sources such as cocoa, coﬀee,
tea, and apples have been associated with various health-
related benefits, including in cardiovascular disease and type 2
diabetes.4–7,51–64 Possible mechanisms include eﬀects on
blood pressure, endothelial function, glucose metabolism,
inflammation, oxidative stress biomarkers, platelet function,
and cholesterol, as well as indirect eﬀects mediated by inter-
action with the gut microbiome.20,21
A portion of the evidence describing the role of polyphenols
in cardiovascular health comes from epidemiologic studies
involving diﬀerent dietary patterns and intake of certain
classes of foods. For example, results from the Prevención con
Dieta Mediterránea (PREDIMED) trial reported an inverse
relationship between total dietary polyphenol intake from
Food & Function Review
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diﬀerent sources as components of a Mediterranean Diet
(e.g. red wine, nuts, and olive oil) and the risk of overall mor-
tality.65,66 An analysis of the same study found an association
between total polyphenol intake and risk of cardiovascular-
related events, independent of other dietary and non-dietary
risk factors.66
Clearly, several factors need to be taken into consideration
when interpreting data from observational studies. For
instance, the increased consumption of polyphenol-rich foods
of plant origin may be balanced by a reduced consumption of
potentially detrimental foods of animal origin, and the latter
may contribute to any apparent relationship between polyphe-
nol consumption and improved function. In the case of
studies involving self-reported food consumption, the accuracy
of recall, diﬀerences in portion size, and potential diﬀerences
in the polyphenol contents of similar foods all markedly
reduce the accuracy of the estimation of polyphenol consump-
tion and may serve to obscure any relationship. Additionally,
this type of research can be confounded by other co-varying
factors, and it often tells us little about causality. However,
observational studies are particularly useful in the formulation
of hypotheses to take forward into controlled intervention
studies, and the convergence of evidence from these diﬀering
types of research is particularly persuasive. Given these factors,
where observational research is cited it should be followed by
consideration of the numerous clinical studies that have evalu-
ated the health eﬀects of administering individual phenolic
compounds and phenolic-rich extracts or foods.
4.1.1. Flavan-3-ols. A number of commonly consumed
foods are high in flavan-3-ols, including tea, nuts, cocoa (cho-
colate), grapes (wine), and legumes.67–69 Observational studies
have reported that flavan-3-ol intake from various dietary
sources produces positive eﬀects on cardiometabolic out-
comes, including reducing the risk for diabetes, and cardio-
vascular-related outcomes (i.e. cholesterol levels, blood
pressure, and myocardial infarction).56,57,70 Regular chocolate
intake has also been associated with a beneficial eﬀect on
arterial stiﬀness, which is involved in the development of sys-
tolic hypertension.71 Results from the large, prospective
Cancer Prevention Study II Nutrition Cohort72 indicated that
total flavonoid intake, including flavan-3-ols, was also associ-
ated with a lower risk of fatal cardiovascular disease. A meta-
analysis of cohort, case-control, and cross-sectional studies
reported a 37% lower risk of any cardiovascular disease (five
studies), a 31% reduction in the risk of diabetes (one study),
and a 29% reduced risk of stroke (three studies) in individuals
who consumer higher levels of cocoa and chocolate; however,
no significant eﬀect was observed on heart failure
(two studies).51 However, the individual studies reviewed did
not distinguish between polyphenol-rich dark chocolate and
low-polyphenol milk/white chocolate, potentially diluting and
underestimating the beneficial eﬀects of the polyphenol-
rich products. Meta-analyses of observational studies have
also reported that consuming foods that are high in flavan-3-
ols can reduce the risk for stroke and myocardial
infarction.4,53,57
In addition, a meta-analysis of randomized, controlled
trials reported that cocoa flavan-3-ols from supplements and
dietary sources produce modest but significant improvements
in cardiometabolic biomarkers, including lipid metabolism,
insulin resistance, and systemic inflammation.60 In a separate
meta-analysis of randomized, controlled trials, dark chocolate
and flavan-3-ol-rich cocoa products were shown to be superior
to placebo in reducing diastolic pre-hypertension and systolic
hypertension, but no significant reduction in mean systolic
blood pressure <140 mmHg or diastolic blood pressure
<80 mmHg was observed.61 A separate meta-analysis of ran-
domized, controlled trials that evaluated flavonoid-rich foods,
including those that are rich in flavan-3-ols, reported signifi-
cant reductions in cardiovascular disease risk factors, includ-
ing flow-mediated dilation (FMD).5 Furthermore, based on the
results of another meta-analysis of randomized, controlled
trials, diﬀerent classes of flavonoids, in particular the flavan-3-
ols, may have diﬀerential eﬀects on FMD and blood pressure
that may be dose dependent.73 Other meta-analyses of ran-
domized, controlled trials have investigated the eﬀects of cho-
colate, cocoa, or cocoa flavan-3-ols intake and found statisti-
cally significant beneficial eﬀects on lipid metabolism, insulin
resistance, mean arterial pressure, and systemic inflammation
and marginally significant eﬀects on LDL and HDL chole-
sterol.60,62,74 A possible independent mechanism for these
eﬀects was proposed to be augmentation of NO status that was
accompanied by enhanced endothelial function and lower sys-
tolic blood pressure.75,76
In a prospective cohort study, flavan-3-ols found in cocoa
and tea have been shown to reduce the risk for cardiovascular
disease mortality.77 A meta-analysis of prospective cohort,
case-control, and cross-sectional studies suggested that higher
levels of dietary tea consumption can reduce the risk of
stroke.53 However, another meta-analysis concluded that black
tea consumption had no significant eﬀect on total, LDL, or
HDL cholesterol,59 suggesting that the eﬀects of flavan-3-ols
on lipid parameters are likely small. A meta-analysis of ran-
domized, controlled trials reported that green tea flavan-3-ols
with or without caﬀeine significantly reduced fasting glucose
but produced no eﬀects on other diabetes-related outcomes.78
Another meta-analysis of randomized, controlled trials indi-
cated that higher doses of epicatechin were related to improve-
ments in biomarkers for cardiovascular disease risk factors
such as FMD and systolic and diastolic blood pressure.62 On
balance, the positive eﬀects of tea polyphenols on cardio-
vascular disease relate to overall improvements in vascular
function79 and blood pressure.80 It is important to consider
that during the production of black tea most of the catechins
are oxidized to condensed flavonoids such as theaflavins and
thearubigins. These have complex chemical structures, and
their biological activities and participation in the health
benefits of tea are still being defined.80,81
4.1.2. Anthocyanins. Anthocyanins are flavonoids that are
mainly found in red and blue fruits and vegetables, in particu-
lar blueberries, raspberries, red grapes, and cherries. After
being consumed, anthocyanins, like other polyphenols, are
Review Food & Function
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metabolized by the host and the microbiome to form active
metabolites that have anti-inflammatory properties and
produce positive vascular eﬀects.82 Prospective cohort studies
have demonstrated that high intake of anthocyanins is associ-
ated with a reduced risk of myocardial infarction in men and
women and produce other positive eﬀects on cardiovascular
risk factors.82–84 Two meta-analyses of randomized, controlled
trials that evaluated consumption of diﬀerent sources of
anthocyanins (e.g. juices, whole berries, extracts) was associ-
ated with a significant reduction in LDL cholesterol, systolic
blood pressure, fasting glucose, HbA1c, and body mass
index.64,85 A recently published meta-analysis of randomized,
controlled trials that utilized a purified anthocyanin sup-
plement reported significant benefits in glycemic control and
lipid parameters in individuals with pre-diabetes or early
untreated diabetes.86 A meta-analysis of randomized, con-
trolled trials that evaluated consumption of anthocyanin-rich
foods or supplements reported improvements in vascular func-
tioning, such as FMD and arterial stiﬀness,87 while another
meta-analysis reported significant reductions in triglycerides
and total and LDL cholesterol.88
4.1.3. Stilbenes. Resveratrol is a stilbene and is principally
found in grapes, red wine, and berries.89 Resveratrol has been
widely studied, and several mechanisms of action have been
proposed, including inhibition of cytokine release and modu-
lation of NO synthesis,89 resulting in anti-inflammatory and
antioxidant actions. A relevant mechanism of action for resver-
atrol is the activation of sirtuins,90 which have been associated
with a delay of aging.91 A meta-analysis of randomized, con-
trolled trials reported that resveratrol supplementation signifi-
cantly reduced fasting glucose, total cholesterol, C-reactive
protein (CRP), and systolic and diastolic blood pressure; these
eﬀects were particularly pronounced in those with pre-existing
NCDs (e.g. type 2 diabetes, cardiovascular disease).92 However,
two older meta-analyses reported that resveratrol had no eﬀect
on CRP, lipid profiles, and several other cardiovascular risk
factors.93,94 Other meta-analyses of randomized, controlled
trials reported that resveratrol had beneficial eﬀects on non-
alcoholic fatty liver disease by modulating lipid parameters95
and on improved glucose control and insulin sensitivity in
individuals with cardiometabolic conditions.96 Furthermore,
resveratrol has been shown to improve peripheral blood flow,
as assessed by FMD, in overweight or obese individuals follow-
ing administration of single doses and extended periods of
supplementation.97,98
4.1.4. Flavonols. Quercetin is a flavonol that has been
shown to improve endothelial functioning in a randomized,
controlled trial by modulating circulating concentrations of
vasoactive NO products and endothelin-1.99 A randomized,
controlled trial that evaluated a flavonoid-rich apple reported
increases in plasma quercetin concentrations and significantly
improved endothelial function in individuals at risk for cardio-
vascular disease.58 Another controlled trial conducted with
subjects at risk for cardiovascular disease reported that querce-
tin supplementation significantly reduced systolic blood
pressure and LDL cholesterol.100 A meta-analysis of random-
ized, controlled trials conducted with quercetin supplements
observed a significant reduction in systolic and diastolic blood
pressure, particularly at doses ≥500 mg day−1.63 However,
some individual studies reported no significant eﬀect of iso-
lated or pure quercetin at lower doses on blood pressure or
endothelial function or on general cardiometabolic
health.101,102
4.2. Eﬀects of polyphenols on cognition
In addition to the eﬀects of polyphenols on cardiometabolic
health, polyphenols are also thought to have beneficial eﬀects
on cognitive functioning. A prospective study of adults in mid-
life found a positive association between total polyphenol
intake and cognitive factors (i.e. language and verbal memory)
assessed over 13 years.103 In longitudinal studies, regular
dietary chocolate consumption has also been shown to reduce
the risk of experiencing cognitive decline.104,105 In addition, in
a meta-analysis of 17 independent observational studies, tea
consumption was found to have an inverse linear relationship
with the incidence of cognitive disorders.6 Other observational
studies have also shown that green and black tea consumption
is related to a lower risk of experiencing cognitive
impairment.106,107 Tea consumption has further been found to
independently reduce the risk for experiencing depression108
and may have a protective eﬀect against Parkinson’s
disease.109
There is clear evidence to suggest that polyphenol-rich pro-
ducts and single polyphenols consistently increase cerebral
blood flow (CBF) or modulate brain activity after single
doses110–117 and longer periods of supplementation.118–124
However, while most of these CBF studies included an assess-
ment of cognitive task performance or mood, only a very small
minority117,123,124 reported any significant improvements in
these domains in comparison with placebo.
In long-term intervention studies, the strongest evidence of
flavan-3-ols producing benefits in cognition comes from two
studies with similar methodologies conducted in healthy
elderly participants125 and suﬀerers of age-related cognitive
impairment (n = 90 per study).126 Subjects consumed drinks
with low (control), medium (520 mg), or high (990 mg) flavan-
3-ol content over an 8-week treatment period. Both studies
reported that the high-flavan-3-ol drink reduced insulin resis-
tance, blood pressure, and lipid peroxidation and improved
attention and executive function. Similar results were observed
in those who consumed the medium-flavan-3-ol content
drinks for the executive functioning task, but no improvement
on the attention task was observed.125,126 These observed
benefits of flavan-3-ols are further supported by a study that
enrolled 40 elderly participants who were supplemented over
12 weeks with 494 mg of flavan-3-ols showing improved scores
on a composite cognitive measure derived from a battery of
tasks.127 Furthermore, blood levels of brain-derived neuro-
trophic factor, a protein involved in the survival, growth, and
diﬀerentiation of new neurons and synapses, were also
increased by flavan-3-ol supplementation.127
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5. Polyphenols and the potential
interaction with other bioactive food
components
When interpreting the results of many of the clinical studies
conducted to assess the influence of polyphenols on a health
parameter, consideration of whether the interventions were
based on consumption of whole foods, purified extracts, or
isolated compounds must be made.128 Indeed, the eﬀects of
potentially complex interventions with multiple bioactive com-
ponents, as in the case of whole foods, have to be carefully
interpreted. Advantageous complementary, additive, or syner-
gistic interactions between polyphenols and/or other classes of
phytochemicals, as well as negative or neutralizing eﬀects of
diﬀerent compounds, are situations that need attention. In
this direction, there is a growing need for properly designed
in vitro, animal, and human intervention studies considering
the potentiality of such interactions.
An example of the importance of the interactions between
polyphenols and other substances is provided by the study of
cocoa products in vascular health. Primarily, the vascular
eﬀects of cocoa are attributed to flavan-3-ols, but the presence
of comparatively low amounts of caﬀeine can also produce vas-
cular eﬀects. As a result, intervention studies have typically
matched the methylxanthine (i.e. caﬀeine) content for the test
and control treatments.129 While it seems appropriate to
match caﬀeine content to separate out the eﬀects of the flavan-
3-ols, additional considerations should be taken because of
the potential for interactions between flavan-3-ols and
caﬀeine. A recent randomized, controlled trial reported that
the vascular eﬀects of cocoa flavanols, including FMD, were
enhanced by the co-ingestion of methylxanthines, which were
associated with an increase in plasma concentrations of epica-
techin-related metabolites.129 Another study in this direction
shows that the bioavailability of epigallocatechin-3-gallate
(ECGC) is increased when consumed with caﬀeine.130 The
authors suggest caﬀeine suppresses the conjugation of ECGC
with increases observed in plasma concentrations, but these
interactions may extend beyond increasing bioavailability. It
has been suggested that the thermogenic eﬀects of ECGC
present in green tea extracts are driven at least in part by tea
flavanols, caﬀeine, and their combined eﬀects on norepi-
nephrine.131 The increases in thermogenesis are likely due to a
combined eﬀect in which the flavanols inhibit catechol
O-methyltransferase, prolonging the duration of norepi-
nephrine retention in the synaptic cleft, while caﬀeine inhibits
the action of phosphodiesterase in cyclic AMP in the cells of
adipose tissue, both resulting in a prolonged eﬀect of norepi-
nephrine on thermogenesis.131 In another recent randomized,
controlled, cross-over study by Boolani et al., the addition of
caﬀeine to cocoa may have acted to improve accuracy and
reduce omission errors on the Bakan primary task.132
However, due to the inclusion of a control group that did not
receive caﬀeine, it is diﬃcult to diﬀerentiate the eﬀects of the
caﬀeine from the cocoa polyphenols. There is also a large body
of research that attributes the cognitive eﬀects of tea and
coﬀee to caﬀeine without any consideration for any contri-
bution from polyphenols.133,134 However, if caﬀeine were the
only active component, tea and coﬀee with the same caﬀeine
content would be expected to have similar eﬀects. Evidence
from intervention trials directly comparing single doses of tea
and coﬀee also shows that their eﬀects diﬀer in terms of physio-
logical responses135 and psychological functioning.136,137
Similarly, tea, when compared directly with its caﬀeine content,
has diﬀerent eﬀects than caﬀeine alone on stress responses,
mood, and overall somatic metabolism.138,139 As an example of
the physiological eﬀects, one study131 found that green tea
increased fat oxidation and decreased carbohydrate oxidation as
the percent of total energy expenditure over 24 hours in a respir-
atory chamber in comparison to its caﬀeine content alone.
Likewise, coﬀee, when compared directly to its caﬀeine content
alone, has diﬀerent eﬀects on blood pressure,140 physical endur-
ance performance,141 resistance exercise,142 and plasma levels
of the neurotransmitter epinephrine.141
Polyphenols often occur alongside terpenes in plant-based
products. For instance, standardized Ginkgo biloba extracts
contain ∼24% flavonoids and 6% diterpenes and their deriva-
tives, and both of these components might have separate,
potentially additive, eﬀects on brain function.143 However,
such potential additive eﬀects have never been experimentally
confirmed. Indeed, terpenoids are thought to be the active
component of many herbal extracts that exert eﬀects on
central nervous system function, including valerian root,
which contains iridoids and sesquiterpenes, Panax ginseng,
which is rich in triterpenes, and the Mentha and Salvia (sage)
genera, which predominantly express volatile monoterpenes.144
All of these structural groups of terpenes exert markedly
diﬀerent mechanistic eﬀects relevant to brain function, and
they also co-exist in extracts alongside significant quantities of
polyphenols. To give an example, the cognitive and mood
eﬀects of sage essential oils containing only monoterpenes are
similar to those seen with sage extracts combining terpenes
with phenolics.144 Conversely, an aqueous extract of spearmint
containing polyphenols but none of the plant’s substantial
monoterpene content improved cognitive function in older
adults.145 Similarly, lemon balm, which has been shown to
produce acute anxiolytic and cognitive eﬀects, contains flavo-
noids as well as monoterpenoid aldehydes and glycosides.146
Therefore, it appears that diﬀerent classes of terpenes have dis-
tinct mechanisms of action that produce varying eﬀects.
The cardiovascular benefits that have been observed with
polyphenols may also be due to the cooperative eﬀects with
other bioactive compounds, such as nitrates and fibers.
Consuming polyphenol-rich fruits with a Western style meal
can attenuate the resulting inflammatory processes associated
with high-energy dietary patterns.147 In one study, consuming
either green tea or fruit-based polyphenols and fiber had posi-
tive eﬀects on post-prandial glucose and insulin when con-
sumed together with starchy food.148 In a recent study, pome-
granate juice consumption modulated the post-prandial glyce-
mic response; however, the same polyphenols present in
Review Food & Function
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pomegranates but taken as a supplement did not. The authors
of the work consider that this was possibly due to poor mixing
of the polyphenol punicalagin in extract form in the stomach
and intestine.149 Polyphenols have also been shown to protect
readily oxidized nutrients, in particular, lipids such as polyun-
saturated fatty acids, which can enhance their beneficial
eﬀects.150 Flavonoids (e.g. quercetin, (−)-epicatechin, (−)-epi-
gallocatechin gallate) can also protect α-tocopherol from oxi-
dation during digestion, which increases α-tocopherol concen-
trations in plasma and liver.151,152 Two separate studies from
the same group evaluating the eﬀect of consuming flavonoid-
rich apples with nitrate-rich spinach on NO status reported
conflicting results.75,153 One study reported that the combi-
nation of these two foods augmented NO status, while not
showing any impact on cognitive function.153 The second
study reported a significant interaction between higher NO
status (which was independently but not synergistically related
to the consumption of flavonoid-rich apples with nitrate-rich
spinach) and endothelial dysfunction, as well as increased
blood pressure.75 Although this group later demonstrated that
quercetin had no eﬀects on blood pressure or endothelial
function,101 a more recent study found that whole apples rich
in flavonoids (including the skin) significantly improved endo-
thelial function compared with low-flavonoid apples (without
the skin).58 Notably, plasma quercetin levels were increased
following consumption of the flavonoid-rich apples. The
eﬀects of quercetin on endothelial function are thought to be
due, in part, to their eﬀects on NO, possibly by stimulating
endothelial NO synthase activity. This study, however, was not
able to detect small changes in nitrite and nitrate concen-
trations,58 which may relate to technical issues associated with
measuring nitrite as a marker of NO production in frozen
samples rather than fresh plasma.154
6. Conclusions
Consuming polyphenol-rich foods has been associated with a
range of health benefits, including optimizing cardiometabolic
health and to a lesser extent positively impacting brain func-
tioning in humans. However, the actual mechanisms for these
eﬀects have not been fully established. The complex relation-
ships between polyphenols and the gut microbiome, as well as
the interaction between the microbiome and health outcomes,
should be considered as relevant participants in these health
eﬀects that warrant further research. Furthermore, the possi-
bility of interactions with other bioactives present in foods or
that can be administered as supplements, (e.g. fiber, terpe-
noids, and alkaloids) deserves consideration when designing
future studies.
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